S. Michael Owens
Fundador en InterveXion Therapeutics LLC .
Perfil
S.
Michael Owens is the founder of InterveXion Therapeutics LLC, founded in 2004, where he holds the title of Chief Scientific Officer.
He was also the founder of Arkansas Biosciences Institute, founded in 2001, where he held the title of Director in 2002.
Currently, Dr. Owens holds the title of Principal at The University of Arkansas.
Cargos activos de S. Michael Owens
Empresas | Cargo | Inicio |
---|---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Fundador | 17/09/2009 |
The University of Arkansas | Corporate Officer/Principal | 17/09/2009 |
Antiguos cargos conocidos de S. Michael Owens.
Empresas | Cargo | Fin |
---|---|---|
Arkansas Biosciences Institute | Fundador | 01/01/2002 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
InterveXion Therapeutics LLC
InterveXion Therapeutics LLC Pharmaceuticals: MajorHealth Technology InterveXion Therapeutics LLC develops drugs and antibody-based therapies. The firm develops monoclonal antibodies to treat substance abuse from PCP and methamphetamine. The company was founded by S. Michael Owens, W. Brooks Gentry, Ralph Henry, Misty Stevens and Gerald A. Damerow in 2004 and is headquartered in Little Rock, AR. | Health Technology |
Arkansas Biosciences Institute |
- Bolsa de valores
- Insiders
- S. Michael Owens